The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer

Metastatic breast cancer is refractory to conventional therapies and is an end-stage disease. RUNX2 is a transcription factor that becomes oncogenic when aberrantly expressed in multiple tumor types, including breast cancer, supporting tumor progression and metastases. Our previous work demonstrated...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Horm Cancer
Egile Nagusiak: Bolf, Eric L., Gillis, Noelle E., Barnum, Michael S., Beaudet, Caitlin M., Yu, Grace Y., Tomczak, Jennifer A., Stein, Janet L., Lian, Jane B., Stein, Gary S., Carr, Frances E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2019
Gaiak:
Original Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8007220/
https://ncbi.nlm.nih.gov/pubmed/31865591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-019-00373-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak